The results showed that treatment with either compound alone effectively reduced subcutaneous tumor growth; however, co‐administration of PD‐1 with Nsun2‐i4 in combination demonstrated a significantly enhanced inhibitory effect on tumor growth compared with individual treatments (Figure 6K–M). This evidence concerns the gene NSUN2 and neoplasm.